| REGENERON PHARMACEUTICALS |
| USA |
| Gesundheit |
| US75886F1075 / 881535 |
| RGO (Frankfurt) / REGN (NASDAQ) |
| FRA:RGO, ETR:RGO, RGO:GR, NASDAQ:REGN |
| https://www.regeneron.com.. |
|
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, develops, manufactures, and commercializes medicines for people with serious diseases. Its portfolio spans treatments in eye care, immunology, oncology, cardiovascular and met..
>Volltext.. |
| 89592.92 Mio. EUR |
| 83760.92 Mio. EUR |
| 15367.17 Mio. EUR |
| 5135.52 Mio. EUR |
| 4381.45 Mio. EUR |
| 42.73 EUR |
| 2462.03 Mio. EUR |
| 3339.34 Mio. EUR |
| 4407.46 Mio. EUR |
| 1.5 |
| 22.84% |
| 9% |
| 3.18 EUR |
| 0.39% |
| 0.39% |
| 18.08.26 - 0.80548596€ 20.05.26 - 0.808306€ >weitere anzeigen... |
| 8 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 42.193.195 Euro. |
| REGENERON |
| 18.11.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|